동물용 의약품 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 대상 동물별, 유통 채널별, 용도별, 지역별, 부문별 예측(2026-2033년)

Animal Health Market Summary

The global animal health market size was estimated at USD 68.7 billion in 2025 and is projected to reach USD 156.0 billion by 2033, growing at a CAGR of 11.0% from 2026 to 2033. Factors driving the market growth include rising animal health expenditure, the increasing inculcation of Artificial Intelligence (AI), evolving regulatory scenario, prevalence of diseases in animals, concerns over zoonoses, initiatives by key companies, uptake of pet insurance, and pet humanization.

However, the most dominant factor is the increasing inculcation of AI across multiple technologies in the animal health sector. One of the key drivers for the market is the inculcation of AI into various sectors within the animal health sector. The integration of artificial intelligence across the animal health sector is driving structural change in clinical practice, diagnostics, and herd management. Veterinary providers are adopting AI-enabled imaging tools that assist in detecting abnormalities during surgical and radiology procedures. According to February 2026 press release, research institutions such as the German Cancer Research Center are developing AI systems trained on animal data to improve imaging precision and surgical outcomes. In companion animal care, companies such as Zoetis are advancing diagnostic platforms that apply algorithm-based analysis to deliver faster and more accurate results. These developments are reducing diagnostic turnaround time, improving case management, and increasing demand for technology-enabled veterinary services.

Infrastructure development is strengthening this transition. According to a February 2026 blog, academic institutions including Ross University School of Veterinary Medicine are incorporating AI-driven predictive analytics into veterinary education and clinical training. Furthermore, according to February 2026 article, national forums such as the conference hosted by Tamil Nadu Veterinary and Animal Sciences University are promoting collaboration between technology developers, veterinarians, and policymakers. Cross-border initiatives, including the India-Germany partnership reported by The Times of India in its February 2026 article are expanding research networks focused on AI-enabled veterinary solutions. In addition, in February 2026, livestock monitoring platforms such as FlockVision, developed by GD Animal Health, are applying behavior-detection algorithms to improve flock management and disease surveillance. These investments are building a data-driven ecosystem that supports scalable adoption.

Future growth opportunities are emerging across diagnostics, remote monitoring, and precision livestock management. AI-based tools are expected to expand into wearable devices, herd-level disease forecasting, and automated treatment planning. As data availability increases and cloud-based systems gain wider acceptance, veterinary practices are likely to integrate predictive models into routine workflows. This shift is positioning AI as a central growth catalyst within the global animal health industry. Such initiatives reflect a growing global focus on AI in animal health, aiming to improve animal welfare and support sustainable agricultural practices through innovative technologies.

Global Animal Health Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global animal health market report based on product, animal, distribution channel, end use, and region.

• Animal Outlook (Revenue, USD Million, 2021 - 2033)
• Production Animals
  • Poultry
  • Swine
  • Cattle
  • Sheep & Goats
  • Fish
• Companion Animals
  • Dogs
  • Cats
  • Horses
  • Others
• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Biologics
  • Vaccines
  • Modified/ Attenuated Live
  • Inactivated (Killed)
  • Other Vaccines
  • Other Biologics
  • Pharmaceuticals
  • Parasiticides
  • Anti-infectives
  • Anti-inflammatory
  • Analgesics
  • Others
• Medicinal Feed Additives
• Diagnostics
  • Consumables, reagents and kits
  • Instruments and devices
• Equipment & Disposables
  • Critical Care Consumables
  • Anesthesia Equipment
  • Fluid Management Equipment
  • Temperature Management Equipment
  • Rescue & Resuscitation Equipment
  • Research Equipment
  • Patient Monitoring Equipment
• Others
  • Veterinary Telehealth
  • Veterinary Software
  • Livestock Monitoring
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Retail
• E-Commerce
• Hospital/ Clinic Pharmacy
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Veterinary Reference Laboratories
• Point-of-care Testing/In-house Testing
• Veterinary Hospitals & Clinics
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Sweden
  • Denmark
  • Norway
  • Russia
  • Ireland
  • Poland
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Indonesia
  • Thailand
  • Australia
  • South Korea
  • Philippines
  • Malaysia
  • Singapore
• Rest of Asia Pacific
  • Latin America
  • Brazil
  • Argentina
  • Colombia
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Turkey
  • UAE
  • Kuwait
  • Egypt
  • Iran
  • Israel
  • Qatar
  • Oman
  • Rest of MEA

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Model 1 Analysis
  • 1.7.2. Model 2 Analysis
  • 1.7.3. Model 3 Analysis
  • 1.7.4. Global Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Animal Health Market Variables, Trends, & Scope

• 3.1. Market Dynamics
  • 3.1.1. Market Drivers Analysis
    • 3.1.1.1. Increasing expenditure on pets
    • 3.1.1.2. Increasing advancements in veterinary medicine
    • 3.1.1.3. Increasing medicalization rate
    • 3.1.1.4. Increasing demand for animal protein
    • 3.1.1.5. Increasing prevalence of diseases in animals
    • 3.1.1.6. Rising Government Initiatives
    • 3.1.1.7. Increasing Inculcation Of Artificial Intelligence (AI)
    • 3.1.1.8. Evolving Regulatory Scenario
  • 3.1.2. Market Restraints Analysis
    • 3.1.2.1. Complex regulations
    • 3.1.2.2. Limited Awareness and Education
    • 3.1.2.3. High cost of animal care
    • 3.1.2.4. Limited access to veterinary care
  • 3.1.3. Market Opportunity Analysis
  • 3.1.4. Market Challenge Analysis
• 3.2. Animal Health Market Analysis Tools
  • 3.2.1. Porter's Five Forces Analysis
  • 3.2.2. PESTEL Analysis, by SWOT
• 3.3. Estimated Animal Population, by Key Species & Key Countries, 2025
• 3.4. Pricing Analysis
• 3.5. Pet Owner Demographics in Key Countries

Chapter 4. Animal Health Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Animal Health Market: Product Movement Analysis, USD Billion, 2025 & 2033
• 4.3. Biologics
  • 4.3.1. Biologics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.2. Vaccines
    • 4.3.2.1. Vaccines Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.2. Modified/ Attenuated Live
      • 4.3.2.2.1. Modified/ Attenuated Live Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.3. Inactivated (Killed)
      • 4.3.2.3.1. Inactivated (Killed) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.4. Other Vaccines
      • 4.3.2.4.1. Other Vaccines Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.3. Other Biologics
    • 4.3.3.1. Other Biologics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Pharmaceuticals
  • 4.4.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Parasiticides
    • 4.4.2.1. Parasiticides Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Anti-infectives
    • 4.4.3.1. Anti-infectives Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. Anti-inflammatory
    • 4.4.4.1. Anti-inflammatory Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.5. Analgesics
    • 4.4.5.1. Analgesics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.6. Others
    • 4.4.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Diagnostics
  • 4.5.1. Diagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. Consumables, reagents and kits
    • 4.5.2.1. Consumables, reagents and kits Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. Instruments and devices
    • 4.5.3.1. Instruments and devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Equipment & Disposables
  • 4.6.1. Equipment & Disposables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.2. Critical Care Consumables
    • 4.6.2.1. Critical Care Consumables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.3. Anesthesia Equipment
    • 4.6.3.1. Anesthesia Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.4. Fluid Management Equipment
    • 4.6.4.1. Fluid Management Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.5. Temperature Management Equipment
    • 4.6.5.1. Temperature Management Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.6. Rescue & Resuscitation Equipment
    • 4.6.6.1. Rescue & Resuscitation Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.7. Research Equipment
    • 4.6.7.1. Research Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.8. Patient Monitoring Equipment
    • 4.6.8.1. Patient Monitoring Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Medicinal Feed Additives
  • 4.7.1. Medicinal Feed Additives Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Other Products
  • 4.8.1. Other Products Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8.2. Veterinary Telehealth
    • 4.8.2.1. Veterinary Telehealth Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8.3. Veterinary Software
    • 4.8.3.1. Veterinary Software Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8.4. Livestock Monitoring
    • 4.8.4.1. Livestock Monitoring Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Animal Health Market: Distribution Channel Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Animal Health Market: Distribution Channel Movement Analysis, USD Billion, 2025 & 2033
• 5.3. Retail
  • 5.3.1. Retail Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. E-Commerce
  • 5.4.1. E-Commerce Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Hospital/ Clinic Pharmacy
  • 5.5.1. Hospital/ Clinic Pharmacy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Animal Health Market: Animal Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Animal Health Market: Animal Movement Analysis, USD Billion, 2025 & 2033
• 6.3. Production Animals
  • 6.3.1. Production Animals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. Poultry
    • 6.3.2.1. Poultry Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.3. Swine
    • 6.3.3.1. Swine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.4. Cattle
    • 6.3.4.1. Cattle Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.5. Sheep & Goats
    • 6.3.5.1. Sheep & Goats Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.6. Fish
    • 6.3.6.1. Fish Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. Companion Animals
  • 6.4.1. Companion Animals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.2. Dogs
    • 6.4.2.1. Dogs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.3. Cats
    • 6.4.3.1. Cats Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.4. Horses
    • 6.4.4.1. Horses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.5. Others
    • 6.4.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Animal Health Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Animal Health Market: End Use Movement Analysis, USD Billion, 2025 & 2033
• 7.3. Veterinary Reference Laboratories
  • 7.3.1. Veterinary Reference Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.4. Point-of-care Testing/In-house Testing
  • 7.4.1. Point-of-care Testing/In-house Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Veterinary Hospitals & Clinics
  • 7.5.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Others
  • 7.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Animal Health Market: Regional Estimates & Trend Analysis

• 8.1. Animal Health Market Share, By Region, 2025 & 2033, USD Million
• 8.2. Regional Outlook
• 8.3. North America
  • 8.3.1. North America Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Landscape
    • 8.3.2.3. Regulatory Landscape
    • 8.3.2.4. U.S. Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Landscape
    • 8.3.3.3. Regulatory Landscape
    • 8.3.3.4. Canada Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Landscape
    • 8.3.4.3. Regulatory Landscape
    • 8.3.4.4. Mexico Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Landscape
    • 8.4.2.3. Regulatory Landscape
    • 8.4.2.4. UK Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Landscape
    • 8.4.3.3. Regulatory Landscape
    • 8.4.3.4. Germany Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Landscape
    • 8.4.4.3. Regulatory Landscape
    • 8.4.4.4. France Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Landscape
    • 8.4.5.3. Regulatory Landscape
    • 8.4.5.4. Italy Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Landscape
    • 8.4.6.3. Regulatory Landscape
    • 8.4.6.4. Spain Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Landscape
    • 8.4.7.3. Regulatory Landscape
    • 8.4.7.4. Sweden Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Landscape
    • 8.4.8.3. Regulatory Landscape
    • 8.4.8.4. Denmark Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Landscape
    • 8.4.9.3. Regulatory Landscape
    • 8.4.9.4. Norway Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.10. Russia
    • 8.4.10.1. Key Country Dynamics
    • 8.4.10.2. Competitive Landscape
    • 8.4.10.3. Regulatory Landscape
    • 8.4.10.4. Russia Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.11. Netherlands
    • 8.4.11.1. Key Country Dynamics
    • 8.4.11.2. Competitive Landscape
    • 8.4.11.3. Regulatory Landscape
    • 8.4.11.4. Netherlands Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.12. Switzerland
    • 8.4.12.1. Key Country Dynamics
    • 8.4.12.2. Competitive Landscape
    • 8.4.12.3. Regulatory Landscape
    • 8.4.12.4. Switzerland Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.13. Ireland
    • 8.4.13.1. Key Country Dynamics
    • 8.4.13.2. Competitive Landscape
    • 8.4.13.3. Regulatory Landscape
    • 8.4.13.4. Ireland Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.14. Poland
    • 8.4.14.1. Key Country Dynamics
    • 8.4.14.2. Competitive Landscape
    • 8.4.14.3. Regulatory Landscape
    • 8.4.14.4. Poland Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Landscape
    • 8.5.2.3. Regulatory Landscape
    • 8.5.2.4. China Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. Japan
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Landscape
    • 8.5.3.3. Regulatory Landscape
    • 8.5.3.4. Japan Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Landscape
    • 8.5.4.3. Regulatory Landscape
    • 8.5.4.4. India Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Landscape
    • 8.5.5.3. Regulatory Landscape
    • 8.5.5.4. South Korea Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Landscape
    • 8.5.6.3. Regulatory Landscape
    • 8.5.6.4. Australia Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Landscape
    • 8.5.7.3. Regulatory Landscape
    • 8.5.7.4. Thailand Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.8. Indonesia
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competitive Landscape
    • 8.5.8.3. Regulatory Landscape
    • 8.5.8.4. Indonesia Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.9. Philippines
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competitive Landscape
    • 8.5.9.3. Regulatory Landscape
    • 8.5.9.4. Philippines Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.10. Malaysia
    • 8.5.10.1. Key Country Dynamics
    • 8.5.10.2. Competitive Landscape
    • 8.5.10.3. Regulatory Landscape
    • 8.5.10.4. Malaysia Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.11. Singapore
    • 8.5.11.1. Key Country Dynamics
    • 8.5.11.2. Competitive Landscape
    • 8.5.11.3. Regulatory Landscape
    • 8.5.11.4. Singapore Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Landscape
    • 8.6.2.3. Regulatory Landscape
    • 8.6.2.4. Brazil Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Landscape
    • 8.6.3.3. Regulatory Landscape
    • 8.6.3.4. Argentina Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. Middle East and Africa
  • 8.7.1. Middle East and Africa Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Landscape
    • 8.7.2.3. Regulatory Landscape
    • 8.7.2.4. Saudi Arabia Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Landscape
    • 8.7.3.3. Regulatory Landscape
    • 8.7.3.4. UAE Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.4. South Africa
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Landscape
    • 8.7.4.3. Regulatory Landscape
    • 8.7.4.4. South Africa Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Landscape
    • 8.7.5.3. Regulatory Landscape
    • 8.7.5.4. Kuwait Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.6. Turkey
    • 8.7.6.1. Key Country Dynamics
    • 8.7.6.2. Competitive Landscape
    • 8.7.6.3. Regulatory Landscape
    • 8.7.6.4. Turkey Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.7. Iran
    • 8.7.7.1. Key Country Dynamics
    • 8.7.7.2. Competitive Landscape
    • 8.7.7.3. Regulatory Landscape
    • 8.7.7.4. Iran Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.8. Israel
    • 8.7.8.1. Key Country Dynamics
    • 8.7.8.2. Competitive Landscape
    • 8.7.8.3. Regulatory Landscape
    • 8.7.8.4. Israel Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.9. Egypt
    • 8.7.9.1. Key Country Dynamics
    • 8.7.9.2. Competitive Landscape
    • 8.7.9.3. Regulatory Landscape
    • 8.7.9.4. Egypt Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.10. Qatar
    • 8.7.10.1. Key Country Dynamics
    • 8.7.10.2. Competitive Landscape
    • 8.7.10.3. Regulatory Landscape
    • 8.7.10.4. Qatar Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.11. Oman
    • 8.7.11.1. Key Country Dynamics
    • 8.7.11.2. Competitive Landscape
    • 8.7.11.3. Regulatory Landscape
    • 8.7.11.4. Oman Animal Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Company Market Position Analysis/ Heap Map Analysis
• 9.3. Company Profiles
  • 9.3.1. Zoetis
    • 9.3.1.1. Participant's Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Product Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Ceva Sante Animale
    • 9.3.2.1. Participant's Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Product Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Merck & Co., Inc.
    • 9.3.3.1. Participant's Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Product Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Vetoquinol S.A.
    • 9.3.4.1. Participant's Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Product Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Boehringer Ingelheim Gmbh
    • 9.3.5.1. Participant's Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Product Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Elanco
    • 9.3.6.1. Participant's Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Product Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Virbac
    • 9.3.7.1. Participant's Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Product Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Mars Inc.
    • 9.3.8.1. Participant's Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Product Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. Dechra Pharmaceuticals Plc
    • 9.3.9.1. Participant's Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Product Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. Idexx Laboratories, Inc.
    • 9.3.10.1. Participant's Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Product Benchmarking
    • 9.3.10.4. Strategic Initiatives
• 9.4. Strategy Mapping
  • 9.4.1. Mergers & Acquisitions
  • 9.4.2. Partnerships & Collaborations
  • 9.4.3. Others
• 9.5. List of Other Key Manufacturers
• 9.6. List of Distributors by Region